In case you missed it in Monday’s paper, I wrote about Sonus Pharmaceuticals in Bothell, which is planning to grow even as it awaits crucial data from the phase 3 trial of its chemotherapy drug, Tocosol paclitaxel.
Here’s the story, http://www.heraldnet.com/stories/07/03/05/100bus_sonus001.cfm.
Talk to us
- You can tell us about news and ask us about our journalism by emailing newstips@heraldnet.com or by calling 425-339-3428.
- If you have an opinion you wish to share for publication, send a letter to the editor to letters@heraldnet.com or by regular mail to The Daily Herald, Letters, P.O. Box 930, Everett, WA 98206.
- More contact information is here.